Patient information leaflets: friend or foe?

Area of Science:

• Pharmacology
• Patient Education
• Health Communication

Background:

• Medication packaging includes patient information leaflets detailing usage, warnings, and side effects.
• Healthcare providers often do not review these leaflets with patients, while some patients read them extensively.

Discussion:

• The content of PILs, including warnings and precautions, can induce patient worry and uncertainty, negatively impacting treatment compliance.
• While official health agency information is preferred, current PILs require enhancement to be more user-friendly.
• Bridging the gap between technical drug information and patient comprehension is essential for effective pharmacotherapy.

Key Insights:

• Many healthcare providers do not utilize patient information leaflets (PILs) in patient consultations.
• Thorough patient reading of complex PILs can lead to increased anxiety and decreased medication adherence.
• Enhancing the readability and user-friendliness of PILs is vital for improving patient understanding and treatment outcomes.

Outlook:

• Future efforts should focus on redesigning PILs to be more accessible and less intimidating for patients.
• Integrating clear, concise language and patient-centered design principles into PILs will improve health literacy.
• Collaborative development involving healthcare professionals, patients, and regulators can optimize PIL content and format for better public health.